Interaction between α2-autoreceptors and receptors mediating the effects of angiotensin II and bradykinin in the heart of newborn rats

European Journal of Pharmacology

Volumn 453, Issue 2-3, 2002, Pages 265-270

  Mota, Alberto ^a   Guimarães, Serafim ^a  

^a University of Porto   (Portugal)

Author keywords

Angiotensin II; Bradykinin; Newborn; Prejunctional interaction; Protein kinase C; Rat

Indexed keywords

3',4' DIHYDROXY 2 METHYLPROPIOPHENONE; ADENYLATE CYCLASE; ANGIOTENSIN; AUTORECEPTOR; BRADYKININ; CHELERYTHRINE; COCAINE; DRUG RECEPTOR; EPROSARTAN; FORSKOLIN; HYDROCORTISONE; ICATIBANT; NORADRENALIN; PARGYLINE; PHOSPHODIESTERASE INHIBITOR; PROTEIN KINASE C; STAUROSPORINE; TRITIUM; YOHIMBINE; ALKALOID; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; BENZOPHENANTHRIDINE DERIVATIVE; BRADYKININ RECEPTOR; PHENANTHRIDINE DERIVATIVE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; ELECTROSTIMULATION; EVOKED RESPONSE; HEART; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RAT; RECEPTOR BLOCKING; ANIMAL; COMPARATIVE STUDY; DRUG ANTAGONISM; HEART MUSCLE; IN VITRO STUDY; METABOLISM; PHYSIOLOGY; WISTAR RAT;

ADRENERGIC ALPHA-ANTAGONISTS; ALKALOIDS; ANGIOTENSIN II; ANIMALS; ANIMALS, NEWBORN; AUTORECEPTORS; BENZOPHENANTHRIDINES; BRADYKININ; ELECTRIC STIMULATION; FORSKOLIN; MYOCARDIUM; NOREPINEPHRINE; PHENANTHRIDINES; PROTEIN KINASE C; RATS; RATS, WISTAR; RECEPTORS, ANGIOTENSIN; RECEPTORS, BRADYKININ; STAUROSPORINE; YOHIMBINE;

EID: 0037174824     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(02)02425-1     Document Type: Article

References (32)

1. Adler-Graschinsky E. Dual presynaptic effects of 5-hydroxytryptamine on peripheral noradrenergic synapses. J. Auton. Pharmacol. 3:1983;303-315.
2. Anderson R.J., Breckon R., Colston D. Regulation by forskolin of cyclic AMP phosphodiesterase and protein kinase C activity in LLC-PK1 cells. Biochem. J. 279:1991;23-27.
3. 1-receptor antagonist losartan, irbesartan, and telmisartan on angiotensin II-induced facilitation of sympathetic neurotransmission in the rat messenteric artery. J. Cardiovasc. Pharmacol. 38:2001;141-148.
4. Balt J.C., Mathy M.-J., Pfaffendorf M., Van Zwieten P.A. Inhibition of sympathetic neurotransmission and angiotensin II-induced pressor effects in the pithed rat, comparision between valsartan, candesartan, eprosartan and embusartan. J. Hypertens. 19:2001;2241-2250.
5. Bian J.S., Zhang W.M., Pei J.M., Wong T.M. The role of phosphodiesterase in mediating the effect of protein kinase C on cyclic AMP accumulation upon kappa-opioid receptor stimulation in the rat heart. J. Pharmacol. Exp. Ther. 292:2000;1065-1070.
6. 1-receptor mediated increase of noradrenaline release by angiotensin II is seen only in the presence of prejunctional autoinhibition. Mukhopadhyay A.K., Raizada M.K. Tissue Renin-Angiotensin Systems. 1995;293-298 Plenum, New York.
7. Cai J.J., Lee H.C. Protein kinase C isozyme-specific modulation of cyclic AMP-dependent phosphodiesterase in hypertrophic cardiomyopathic hamster hearts. Mol. Pharmacol. 49:1996;81-88.
8. i/o protein-coupled receptors. Br. J. Pharmacol. 129:2000;1095-1102.
9. De Gasparo M., Catt K.J., Inagami T., Wright J.W., Unger T.H. International union of pharmacology: XXIII. The angiotensin II receptors. Pharmacol. Rev. 52:2000;415-472.
10. Dendorfer A., Dominiak P. Characterization of bradykinin receptors mediating cathecolamine release in PC12 cells. Naunyn-Schmiedeberg's Arch. Pharmacol. 351:1995;274-281.
11. Eckly-Michel A.E., Le Bec A., Lugnier C. Chelerythrine, a protein kinase C inhibitor, interacts with cyclic nucleotide phosphodiesterases. Eur. J. Pharmacol. 324:1997;85-88.
12. Edwards R.M., Alyar N., Ohlstein E.H., Weidley E.F., Griffin E., Ezekiel M., Keenam R.M., Ruffolo R.R., Weinstock J. Pharmacological characterisation of the nonpeptide angiotensin II receptor antagonist, SKF108566. J. Pharmacol. Exp. Ther. 260:1992;175-181.
13. Enero M.A., Saidman B.Q. Possible feed-back inhibition of noradrenaline release by purine compounds. Naunyn-Schmiedeberg's Arch. Pharmacol. 297:1977;39-46.
14. Guimarães S., Moura D. Vascular adrenoceptors. An update. Pharmacol. Rev. 53:2001;319-356.
15. Guimarães S., Osswald W. Adrenergic receptors in the veins of the dog. Eur. J. Pharmacol. 5:1969;133-140.
16. Guimarães S., Brandão F., Paiva M.Q. A study of the adrenoceptor-mediator feedback mechanisms by using adrenaline as a false transmitter. Naunyn-Schmiedeberg's Arch. Pharmacol. 305:1978;185-188.
17. Guimarães S., Moura D., Paiva M.Q., Vaz-Da-Silva M.J. Lack of pre- and postjunctional beta adrenoceptor-mediated effects in the canine saphenous vein at birth. J. Pharmacol. Exp. Ther. 268:1994;990-995.
18. Guimarães S., Paiva M.Q., Moura D. Different receptors for angiotensin II and pre-and postjunctional level of the canine mesenteric and pulmonary arteries. Br. J. Pharmacol. 305:1998;185-188.
19. Guimarães S., Pinheiro H., Tavares P., Loio A., Moura D. Differential effects of eprosartan and losartan at prejunctional angiotensin II receptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 363:2001;509-514.
20. Hedquist P. Prostaglandin action on noradrenaline release and mechanical responses in the stimulated guinea-pig vas deferens. Acta Physiol. Scand. 90:1974;86-93.
21. Herbert J.M., Augereau J.M., Gleye J., Maffrand J.P. Chelerythrine is a potent and specific inhibitor of protein kinase C. Biochem. Biophys. Res. Commun. 15:1990;993-999.
22. Jacobowitz O., Chen J., Premont R.T., Iyengar R. Stimulation of specific types of Gs-stimulated adenylyl cyclases by phorbol ester treatment. J. Biol. Chem. 268:1993;3829-3832.
23. Latifpour J., Bylund D.B. Characterizaton of adrenergic receptor biding in rat lung, physiological regulation. J. Pharmacol. Exp. Ther. 224:1983;186-192.
24. 3H]-noradrenaline from rat atria and rabbit ear artery. Br. J. Pharmacol. 84:1985;697-705.
25. Massingham R., Dubocovich M.L., Langer S.Z. The role of presynaptic receptors in the cardiovascular actions of N,N-di-n-propyldopamine in cat and dog. Naunyn-Schmiedeberg's Arch. Dermatol. 314:1980;17-28.
26. 2-autoreceptors and prejunctional receptors mediating a facilitatory effect on noradrenaline release. Pharmacol. Res. 42:2000;383-387.
27. 2-adrenoceptors permits the operation of otherwise silent opioid k-receptors at the sympathetic axons of rabbit jejunal arteries. Naunyn-Schmiedeberg's Arch. Dermatol. 334:1986;48-55.
28. 3H]dopamine release from rat nucleus accumbens slices. Neurochem. Res. 18:1993;285-289.
29. Seamon K., Daly J.W. Activation of adenylate cyclase by the diterpene forskolin does not require the guanine nucleotide regulatory protein. J. Biol. Chem. 256:1981;9799-9801.
30. Starke K. Regulation of noradrenaline release by presynaptic receptor systems. Rev. Physiol. Biochem. Pharmacol. 77:1977;1-124.
31. ++ dependent protein kinase. Biochem. Biophys. Res. Commun. 135:1986;397-402.
32. Vaz-da-Silva M., Magina S., Domingues-Costa A., Moura D., Guimarães S. The role of the endocardium in the facilitatory effect of bradykinin on electrically-induced release of noradrenaline in rat cardiac ventricle. Br. J. Pharmacol. 118:1996;364-368.